Philips officially launches Vereos Digital PET/CT in China. Supported by rigorous clinical evidence, Vereos is the world’s first and only fully digital, clinically proven, PET/CT solution. With proprietary Digital Photon Counting technology for outstanding advances all along the imaging chain, Vereos exemplifies an established total solution to reveal more, earlier, to help you improve patient care and manage costs.

The Vereos PET/CT has an irreplaceable role and value for the examination and treatment of diseases such as tumors, heart diseases and nerve diseases. It can help clinicians to make quick and accurate images-based decisions, according to Zhao Gong, senior marketing director of precision diagnosis business at Philips Greater China. Philips has long been committed to improving patient experience and reducing medical costs, and hopes to accelerate clinical applications of its leading technologies in China, Gong added.